Streetwise Energy Technology Sponsors

Select a name to see a detailed description, expert analysis and contact information.



Notable Quotes

"As of Sept. 30, 2017, POE had no debt and $40M of cash."
– Bill Newman, Mackie Research Capital
"RXII's sd-rxRNA can augment already amazing results in immunotherapy."
– John Vandermosten, Zacks Small-Cap Research
"We are initiating coverage on GYA with a Buy rating."
– Siddharth Rajeev, Fundamental Research Corp.